TOPLOGO

The First Conference of Predictive Oncology:
Translating Emerging Molecular Data into Clinical Practice

לפניכם סיקור הכנס שהתקיים ב-21/12/2012

הסיקור בחסות חברת טבע

 

Hovav Nechushtan M.D Ph.D.Genomic and Predictive studies - initial cases

Hovav Nechushtan M.D Ph.D. 
Sharett Institute of Oncology, Hadassah Hebrew University Hospital 

 


Nir Peled MD PhD FCCPNovel crizotinib-sensitive ALK rearrangement in a patient with metastatic NSCLC

Nir Peled MD PhD FCCP 
Head, Thoracic Cancer Research and Detection Center, Sheba Medical Center 

 


Noa Efrat Ben-Baruch, M.D. NGS reveals acquired resistance to hormonal therapy in breast cancer patient

Noa Efrat Ben-Baruch, M.D. 
Head of Department of Oncology, Kaplan Medical Center 



Alexander Beny, MD.Tailored treatment in CRC and GI cancer

Alexander Beny, MD. 
Head, Gastrointestinal cancer service, Rambam Medical Center, Haifa 

 


Ravit Geva, M.D. The predictive role of ERCC1 status in Oxaliplatin based neoadjuvant therapy for metastatic colorectal cancer (mCRC) to the liver

Ravit Geva, M.D. 
Head, Gastrointestinal malignancies Service Head, Research Unit, Division of Oncology, Tel-Aviv Sourasky Medical Center 

 

 


Ron Epelbaum, M.D.Molecular Profiling – Selected Therapy for the Treatment of Patients with Advanced Pancreaticobiliary Cancer

Ron Epelbaum, M.D. 
Director, Ambulatory Care Unit, Oncology Division, Rambam Health Care Campus, Haifa 

 

 


Aron Popovtzer, M.D.Biological tailored driven treatment for metastatic ACC

Aron Popovtzer, M.D. 

Head & Neck Cancer Unit, Davidoff Cancer Center, Rabin Medical center, Sackler Faculty of Medicine, Tel Aviv University

 

סיקור כנס EBDסיקור כנס EBD
סיקור כנס EBDסיקור כנס EBD
סיקור כנס EBD סיקור כנס EBD
סיקור כנס EBD

בהפקת אלדן הפקות



SignifiCast.come-Med ערוץ החדשות הרפואיות של ישראל